An Assessment of the Safety, Eff icacy, and Acceptability of Intranasal Fentanyl Citrate in the Management of Cancer-Related Breakthrough Pain
- 1 October 2000
- journal article
- research article
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 20 (4) , 253-258
- https://doi.org/10.1016/s0885-3924(00)00180-9
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Characterization of Breakthrough Pain by Hospice Patients and Their CaregiversJournal of Pain and Symptom Management, 1998
- Preliminary Clinical use of a Patient-Controlled Intranasal Analgesia (PCINA) DeviceAnaesthesia and Intensive Care, 1997
- Patient-Controlled Intranasal AnalgesiaAnesthesia & Analgesia, 1996
- Intranasal fentanyl titration for postoperative pain management in an unselected populationAnaesthesia, 1993
- Pharmakokinetische Studie zur intranasalen Gabe von FentanylDer Schmerz, 1993
- Postoperative Pain Management by Intranasal Demand-adapted Fentanyl TitrationAnesthesiology, 1992
- Breakthrough pain: definition, prevalence and characteristicsPAIN®, 1990
- INTRANASAL MIDAZOLAM PREMEDICATION IN PRE-SCHOOL CHILDREN.Anesthesia & Analgesia, 1988
- INTRANASAL KETAMINE AS INDUCTION ADJUNCT IN CHILDRENAnesthesiology, 1987
- Clinical Pharmacokinetics of Fentanyl and its Newer DerivativesClinical Pharmacokinetics, 1983